Search Results for author: Engin Dikici

Found 4 papers, 0 papers with code

Prediction of Model Generalizability for Unseen Data: Methodology and Case Study in Brain Metastases Detection in T1-Weighted Contrast-Enhanced 3D MRI

no code implementations15 Dec 2022 Engin Dikici, Xuan Nguyen, Noah Takacs, Luciano M. Prevedello

During the deployment, a given test data's LSM distribution is processed to detect its deviation from the forced distribution; hence, the AI system could predict its generalizability status for any previously unseen data set.

Advancing Brain Metastases Detection in T1-Weighted Contrast-Enhanced 3D MRI using Noisy Student-based Training

no code implementations10 Nov 2021 Engin Dikici, Xuan V. Nguyen, Matthew Bigelow, John. L. Ryu, Luciano M. Prevedello

The framework utilizing only the labeled exams produced 9. 23 false positives for 90% BM detection sensitivity; whereas, the framework using the introduced learning strategy led to ~9% reduction in false detections (i. e., 8. 44) for the same sensitivity level.

Augmented Networks for Faster Brain Metastases Detection in T1-Weighted Contrast-Enhanced 3D MRI

no code implementations27 May 2021 Engin Dikici, Xuan V. Nguyen, Matthew Bigelow, Luciano M. Prevedello

In this study, we introduce a novel BM candidate detection CNN (cdCNN) to replace this classical IP stage.

Artificial Intelligence to Assist in Exclusion of Coronary Atherosclerosis during CCTA Evaluation of Chest-Pain in the Emergency Department: Preparing an Application for Real-World Use

no code implementations10 Aug 2020 Richard D. White, Barbaros S. Erdal, Mutlu Demirer, Vikash Gupta, Matthew T. Bigelow, Engin Dikici, Sema Candemir, Mauricio S. Galizia, Jessica L. Carpenter, Thomas P. O Donnell, Abdul H. Halabi, Luciano M. Prevedello

The two-phase approach consisted of (1) Phase 1 - focused on the development and preliminary testing of an algorithm for vessel-centerline extraction classification in a balanced study population (n = 500 with 50% disease prevalence) derived by retrospective random case selection; and (2) Phase 2 - concerned with simulated-clinical Trialing of the developed algorithm on a per-case basis in a more real-world study population (n = 100 with 28% disease prevalence) from an ED chest-pain series.

Cannot find the paper you are looking for? You can Submit a new open access paper.